🇺🇸 FDA
Pipeline program

allogeneic human mesenchymal stem cells (hMSCs)

20200566

Phase 2 mab active

Quick answer

allogeneic human mesenchymal stem cells (hMSCs) for Non-ischemic Dilated Cardiomyopathy is a Phase 2 program (mab) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Non-ischemic Dilated Cardiomyopathy
Phase
Phase 2
Modality
mab
Status
active

Clinical trials